4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-22-000148
Director sold 20,000 shares at $30.48 ($609,600)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessier-Lavigne Marc Director | 2022-11-23 | Sale | −20,000 | $30.48 | $609,600 | 1,870,356 | D |
| Open-market sales · 20,000 sh · avg $30.48 · $609,600 | |||||||
Loading xslF345X03/wf-form4_166968178535428.xml…